helenalin has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Wang, F; Yang, M; Yang, Y; Yu, X; Zhang, W; Zhang, Y | 1 |
| Chung, LW; Jin, F; Khuri, FR; Liu, X; Lotan, R; Sun, SY; Yue, P; Zhou, Z | 1 |
2 other study(ies) available for helenalin and Prostatic Neoplasms
| Article | Year |
|---|---|
Helenalin Facilitates Reactive Oxygen Species-Mediated Apoptosis and Cell Cycle Arrest by Targeting Thioredoxin Reductase-1 in Human Prostate Cancer Cells.
Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; G1 Phase Cell Cycle Checkpoints; Humans; Male; Prostatic Neoplasms; Reactive Oxygen Species; Sesquiterpenes, Guaiane; Thioredoxin Reductase 1 | 2021 |
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 8; Caspases; Cell Line, Tumor; Humans; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Retinoids; Sesquiterpenes; Sesquiterpenes, Guaiane; Up-Regulation | 2005 |